1. MunichCancerTalks
  2. Devices
  3. nCounter® Analysis System by NanoString, a Bruker Company // Digital Single Molecule Quantification

nCounter® Analysis System by NanoString, a Bruker Company // Digital Single Molecule Quantification

NanoString, a Bruker Company
nCounter® Analysis System / Image provided by NanoString, a Bruker Company

The nCounter technology allows direct quantification of up to 800 targets in a single assay without the necessity of amplifying target molecules. Possibility to measure mRNA, miRNA, lncRNA, dsDNA, und ssDNA (pre-designed or customized code sets available; multiple samples can be multiplexed) in a variety of specimens (tissue biopsies, blood, bone marrow, etc.). No library preparation or sophisticated pre-analytical processing required.
https://nanostring.com/products/ncounter-analysis-system/sprint-profiler/


  • Contact
    Michael Heide, Medizinische Klinik III, ELLF, LMU Klinikum, michael.heide@med.uni-muenchen.de
    Prof. Dr. Oliver Weigert, Medizinische Klinik III, ELLF, LMU Klinikum, oliver.weigert@med.uni-muenchen.de

  • Location of device
    Experimentelle Leukämie- und Lymphom-Forschung (ELLF)
    Max-Lebsche-Platz 30, 81377 München

  • Service & Costs
    Technical support via Weigert lab
    User bears the cost of consumables, currently no user fee applied


Keywords: NGSD, spatialD